LA JOLLA, Calif., October 7, 2008 — Burnham Institute for Medical Research today announced that scientists have created a peptide that binds to Bcl-2, a protein that protects cancer cells from programmed cell death, and converts it into a cancer cell killer. The research, which was published as the featured article in the October 7 edition of Cancer Cell, may lead to new cancer treatments.
LA JOLLA, Calif., October 13, 2008 — Burnham Institute for Medical Research today announced that five of the Institutes postdoctoral research associates will be honored with Fishman Fund Awards to recognize their commitment to basic biomedical research. The awardees will receive $5,000 grants to be used to further their education and career development.
LA JOLLA, Calif., December 1, 2008Researchers at the Burnham Institute for Medical Research have shown in both fruit flies and humans that genes involved in embryonic heart development are also integral to adult heart function. The study, led by Rolf Bodmer, Ph.D., was published in Proceedings of National Academy of Sciences.
The National Institute of Allergy and Infectious Diseases estimates that up to 45 percent of deaths in the developed world involve chronic fibrotic processes. Under a patent license from the Burnham Institute for Medical Research (Burnham) in which Burnham researcher Dr. Erkki Ruoslahti is a named inventor, Genzyme Corporation is conducting clinical trials on GC-1008, an anti-fibrotic drug.
Contact: Cindy Fox Aisen firstname.lastname@example.org 317-274-7722 Indiana University School of Medicine Discovery may lead to new treatments for late-stage cancers INDIANAPOLIS – Researchers from the Indiana University School of Medicine and colleagues at the University of Texas Southwestern and Case Western University have …
Contact: Robert Nellis email@example.com 507-284-5005 Mayo Clinic Animal study demonstrates how whole chromosome changes cause cancer ROCHESTER, Minn. — Mayo Clinic researchers have proven the longstanding theory that changes in the number of whole chromosomes — called aneuploidy — can cause cancer by eli…
Contact: Josh Baxt firstname.lastname@example.org 858-795-5236 Burnham Institute Peptide delivers anti-cancer compounds to where they can do the most good (Santa Barbara, Calif.) – Researchers at Burnham Institute for Medical Research at University of California, Santa Barbara have identified a peptide (a chain of amino acids…